V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010131 | 190007083 | 0 | 31.3 | null | 2017-08-18 | 2018-12-31 | Cyclophosphamide + Topotecan | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101245049 |
| 190010137 | 190007084 | 1.56 | 64.6 | Neo-adjuvant (N) | 2018-05-25 | 2018-06-02 | DOXORUBICIN | 02 | Y | DOXORUBICIN | 100807503 |
| 190010146 | 190007085 | 1.54 | 55.8 | Adjuvant (A) | 2018-08-24 | 2018-08-31 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | BEVACIZUMAB + IRINOTECAN + TEMOZOLOMIDE | 100523946 |
| 190010150 | 190007086 | 0 | 54.3 | Palliative (P) | 2017-12-09 | 2018-10-26 | Capecitabine + Streptozocin | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100080628 |
| 190010151 | 190007087 | null | 72.7 | Palliative (P) | 2019-10-10 | 2019-11-04 | Capecitabine | 02 | null | DINUTUXIMAB BETA | 101185899 |
| 190010174 | 190007088 | 1.68 | 59.2 | Palliative (P) | 2019-10-07 | 2019-12-02 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 100302019 |
| 190010178 | 190007089 | 1.73 | 35.4 | Curative (C) | 2018-08-26 | 2019-08-08 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101243503 |
| 190010184 | 190007090 | 0 | 0 | Curative (C) | 2019-04-27 | 2019-05-11 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 101784800 |
| 190010207 | 190007091 | null | 78 | null | 2017-10-28 | 2018-06-15 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 101468612 |
| 190010208 | 190007092 | 0 | 50.4 | Palliative (P) | 2019-11-01 | 2019-11-02 | CAV | 2 | null | CISPLATIN + DOXORUBICIN | 100558816 |
| 190010215 | 190007093 | 0 | 63.1 | Adjuvant (A) | 2020-01-18 | 2020-02-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | EW EUROEWING 2012 ARM B VDC/IE | 100957220 |
| 190010216 | 190007094 | 0 | 30.8 | Palliative (P) | 2018-11-13 | 2018-11-19 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 101755258 |
| 190010232 | 190007095 | 1.81 | 65.05 | Adjuvant (A) | 2020-08-13 | 2021-01-14 | NB HRNBL-1 Isotretinoin | 02 | N | OST MIFAMURTIDE | 100717091 |
| 190010245 | 190007096 | 1.53 | 42.9 | Neo-adjuvant (N) | 2019-03-08 | 2019-04-01 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 101194627 |
| 190010254 | 190007097 | 1.66 | 45.8 | Palliative (P) | 2017-08-06 | 2018-02-05 | PEMBROLIZUMAB | N | N | TRIAL | 101655316 |
| 190010258 | 190007098 | 0 | 56.9 | Neo-adjuvant (N) | null | 2016-10-22 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100204570 |
| 190010259 | 190007099 | 0 | 40 | Palliative (P) | 2019-03-04 | 2019-03-31 | EVEROLIMUS | N | N | TRABECTEDIN | 101864734 |
| 190010287 | 190007100 | 0 | 25.1 | Curative (C) | 2018-10-18 | 2018-10-28 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | DOCETAXEL + GEMCITABINE | 100344296 |
| 190010293 | 190007101 | 1.76 | 123 | Curative (C) | 2018-08-05 | 2018-09-07 | DOCETAXEL + GEMCITABINE | 02 | Y | DOCETAXEL + GEMCITABINE | 101826975 |
| 190010295 | 190007102 | 0 | 40 | Neo-adjuvant (N) | 2020-04-27 | 2020-09-13 | Cisplatin + Radiotherapy | null | null | EURAMOS TRIAL | 101658414 |
| 190010298 | 190007103 | 1.79 | 79 | Curative (C) | 2018-01-24 | 2018-02-21 | METHOTREXATE | 02 | N | METHOTREXATE | 101616146 |
| 190010303 | 190007104 | 1.76 | 97.3 | null | 2016-03-16 | 2016-04-07 | PACLITAXEL | 02 | N | NOT MATCHED | 100662844 |
| 190010305 | 190007105 | 1.61 | 50 | null | 2017-08-19 | 2018-01-13 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100015398 |
| 190010308 | 190007106 | 0 | 60.2 | Palliative (P) | 2018-01-29 | 2018-02-06 | NIVOLUMAB | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100028419 |
| 190010347 | 190007107 | 1.66 | 67.6 | null | 2016-11-16 | 2017-02-06 | DHAP | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100457965 |
| 190010353 | 190007108 | 1.6 | 65.9 | Adjuvant (A) | 2020-12-29 | 2021-05-21 | Ifosfamide | 02 | null | DOCETAXEL | 100566701 |
| 190010358 | 190007109 | 1.73 | 70 | null | 2019-09-30 | 2020-06-07 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100958431 |
| 190010360 | 190007110 | 1.87 | 78 | Palliative (P) | 2019-10-25 | 2019-11-02 | null | 01 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100086863 |
| 190010375 | 190007111 | 1.75 | 93 | Palliative (P) | 2021-07-19 | 2021-07-24 | PAM x 2 post-surgery (cycles 3&4) | N | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100484423 |
| 190010378 | 190007112 | 0 | 40 | Adjuvant (A) | 2021-06-01 | 2021-06-28 | Irinotecan + Temozolomide | null | null | LENALIDOMIDE | 101604181 |
| 190010381 | 190007113 | 1.79 | null | Adjuvant (A) | 2020-07-22 | 2020-08-19 | Trabectedin | 02 | N | EURAMOS TRIAL | 101291508 |
| 190010382 | 190007114 | 1.81 | null | null | 2020-11-12 | 2020-11-13 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100271314 |
| 190010413 | 190007115 | 0 | 48.5 | Palliative (P) | 2017-11-30 | 2018-06-14 | EW EuroEwing 2012 Arm B VC | 02 | null | EURAMOS TRIAL | 101790227 |
| 190010414 | 190007116 | null | 59.2 | Curative (C) | 2017-03-27 | 2017-03-28 | OST Euramos 1 Closed Trial - M | 02 | Y | OST M | 100303566 |
| 190010417 | 190007117 | 0 | 29.8 | null | 2018-09-23 | 2019-01-22 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | TRIAL | 100684600 |
| 190010450 | 190007118 | 1.73 | 83 | Palliative (P) | 2019-03-05 | 2019-04-14 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 101280855 |
| 190010453 | 190007119 | 1.9 | 56.1 | Adjuvant (A) | 2020-05-11 | 2020-05-28 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100633818 |
| 190010459 | 190007120 | 1.85 | 55.4 | Neo-adjuvant (N) | 2017-01-28 | 2017-03-10 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101317669 |
| 190010462 | 190007121 | 1.84 | 96.65 | Curative (C) | 2016-12-12 | 2017-01-10 | OCTREOTIDE | 02 | null | DOXORUBICIN + HD MTX | 101564620 |
| 190010473 | 190007122 | 0 | 42.8 | Palliative (P) | 2020-01-19 | 2020-09-11 | CAPECITABINE + OXALIPLATIN | null | null | TRIAL | 100010762 |
| 190010480 | 190007123 | 0 | 22 | Curative (C) | null | 2017-08-31 | Trabectedin | 01 | null | VAI | 101828403 |
| 190010500 | 190007124 | 0 | 24 | Curative (C) | 2018-09-22 | 2018-09-22 | MAP | N | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101662835 |
| 190010510 | 190007126 | 1.69 | 53.6 | Curative (C) | 2017-12-23 | 2018-02-28 | ETOPOSIDE + IFOSFAMIDE + MESNA | 01 | N | ETOPOSIDE + IFOSFAMIDE | 101045967 |
| 190010523 | 190007127 | 0 | 34.9 | Palliative (P) | 2016-09-16 | 2016-09-20 | OST Euramos 1 Closed Trial - M | null | null | DOXORUBICIN + METHOTREXATE | 100632183 |
| 190010540 | 190007129 | 1.79 | 23.6 | null | 2020-08-22 | 2020-08-24 | OST Euramos 1 Closed Trial - A | 01 | N | OST A | 101310410 |
| 190010549 | 190007131 | 1.57 | 85.5 | Curative (C) | 2019-06-22 | 2019-07-16 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 101624986 |
| 190010554 | 190007132 | 1.69 | 96.6 | null | 2018-08-07 | 2019-01-04 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101448429 |
| 190010589 | 190007133 | 0 | 0 | Adjuvant (A) | null | 2016-12-04 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100945629 |
| 190010596 | 190007135 | 0 | 0 | null | 2018-08-03 | 2018-09-01 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100167309 |
| 190010597 | 190007136 | 1.39 | 99.2 | null | 2017-10-15 | 2018-02-18 | VINCRISTINE | 2 | null | NB HRNBL-1 COJEC IND COURSE B | 100364039 |